Published on in Vol 6, No 3 (2022): March

Preprints (earlier versions) of this paper are available at https://preprints.jmir.org/preprint/33581, first published .
Mobile App Intervention on Reducing the Myeloproliferative Neoplasm Symptom Burden: Pilot Feasibility and Acceptability Study

Mobile App Intervention on Reducing the Myeloproliferative Neoplasm Symptom Burden: Pilot Feasibility and Acceptability Study

Mobile App Intervention on Reducing the Myeloproliferative Neoplasm Symptom Burden: Pilot Feasibility and Acceptability Study

Journals

  1. Amerikanou R, Lambert J, Alimam S. Myeloproliferative neoplasms in adolescents and young adults. Best Practice & Research Clinical Haematology 2022;35(2):101374 View
  2. Guan V, Zhou C, Wan H, Zhou R, Zhang D, Zhang S, Yang W, Voutharoja B, Wang L, Win K, Wang P. A Novel Mobile App for Personalized Dietary Advice Leveraging Persuasive Technology, Computer Vision, and Cloud Computing: Development and Usability Study. JMIR Formative Research 2023;7:e46839 View
  3. Sánchez-Quiñones B, Antón-Maldonado C, Ibarra Vega N, Martorell Mariné I, Santamaria A. Development and Implementation of an eHealth Oncohematonootric Program: Descriptive, Observational, Prospective Cohort Pilot Study. JMIR Formative Research 2024;8:e49574 View
  4. Prentice C, Peven K, Zhaunova L, Nayak V, Radovic T, Klepchukova A, Potts H, Ponzo S. Methods for evaluating the efficacy and effectiveness of direct-to-consumer mobile health apps: a scoping review. BMC Digital Health 2024;2(1) View
  5. Singh S, Peshin S, Larsen A, Gowin K. Optimizing Care: Integrative Oncology in Myeloproliferative Neoplasm. Current Oncology Reports 2024;26(10):1135 View